SC Filed 2022-02-03 Event — SEC 0001193125-22-027013 →

LSP V Cooperatieve U.A. → Eloxx Pharmaceuticals, Inc. ELOX

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

3 transactions

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

9 13D/G filings on this issuer

8 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.78

41,345 shares short · -23.3% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-10-19	Germano Geno J	director	Award	13,587	$12.50	$170K
2026-05-27	Coastlands Capital LP	10%+ owner	J	1,250,000	—	—
2026-05-27	Coastlands Capital LP	10%+ owner	J	1,250,000	$0.01	$13K

Other 13D/G Filings on Eloxx Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-27	SCHEDULE 13G	Aberdeen Group plc	—	—	view →
2026-06-17	SCHEDULE 13G	Coastlands Capital LP	—	—	view →
2026-06-17	SCHEDULE 13G	Domicilium Real Estate Fund III LP	—	—	view →
2026-06-16	SCHEDULE 13G	Stonepine Capital Management, LLC	—	—	view →
2026-06-16	SCHEDULE 13G	EcoR1 Capital, LLC	—	—	view →
2026-06-15	SCHEDULE 13G	Invus Global Management, LLC	—	—	view →
2021-05-21	SC	Pontifax Management III G.P. (2011) Ltd.	—	—	view →
2019-06-26	SC	Pontifax Management III G.P. (2011) Ltd.	—	—	view →

Other Filings by LSP V Cooperatieve U.A.

Filed	Form	Issuer	Stake	Shares
2023-02-24	SC	IMMUNIC, INC. IMUX	—	—	view →
2020-09-04	SC	IMMUNIC, INC. IMUX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →